Tg Therapeutics Inc (TGTX)

Cost of Revenue

$141.00M

TTM · Period ending: · USD

TGTX logo

TGTX Cost of Revenue

Latest reported$141.00M
TGTX TTM Cost of Revenue ($0.00 → $141.00M)
High-resolution chart · PNG

TGTX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
4,565,314
5,400,733
4,059,336
3,384,336
2,744,963
1,614,228
900,000
100,000
-100,000
-100,000
-100,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.